Phibro Animal Health Corporation (PAHC) - Total Assets
Based on the latest financial reports, Phibro Animal Health Corporation (PAHC) holds total assets worth $1.45 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Phibro Animal Health Corporation debt service capacity to assess how comfortably operating cash covers total debt obligations.
Phibro Animal Health Corporation - Total Assets Trend (2000–2025)
This chart illustrates how Phibro Animal Health Corporation's total assets have evolved over time, based on quarterly financial data. See shareholders equity of Phibro Animal Health Corporation for net asset value and shareholders' equity analysis.
Phibro Animal Health Corporation - Asset Composition Analysis
Current Asset Composition (June 2025)
Phibro Animal Health Corporation's total assets of $1.45 Billion consist of 59.6% current assets and 40.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 5.0% |
| Accounts Receivable | $227.98 Million | 16.8% |
| Inventory | $444.43 Million | 32.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $36.47 Million | 2.7% |
| Goodwill | $59.65 Million | 4.4% |
Asset Composition Trend (2000–2025)
This chart illustrates how Phibro Animal Health Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Phibro Animal Health Corporation (PAHC) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Phibro Animal Health Corporation's current assets represent 59.6% of total assets in 2025, an increase from 58.0% in 2000.
- Cash Position: Cash and equivalents constituted 5.0% of total assets in 2025, up from 0.9% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 2.0% in 2000.
- Asset Diversification: The largest asset category is inventory at 32.7% of total assets.
Phibro Animal Health Corporation Competitors by Total Assets
Key competitors of Phibro Animal Health Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329
|
China | CN¥11.59 Billion |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
|
China | CN¥10.21 Billion |
|
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062
|
China | CN¥17.01 Billion |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
China | CN¥13.81 Billion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Zhejiang Tianyu Pharmaceutical Co Ltd
SHE:300702
|
China | CN¥6.56 Billion |
|
Zhejiang Garden Bio-chemical High-tech Co Ltd
SHE:300401
|
China | CN¥5.91 Billion |
|
KPC Pharmaceuticals Inc
SHG:600422
|
China | CN¥12.01 Billion |
Phibro Animal Health Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.17 | 2.91 | 3.04 |
| Quick Ratio | 1.26 | 1.23 | 1.72 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $612.20 Million | $509.54 Million | $334.79 Million |
Phibro Animal Health Corporation - Advanced Valuation Insights
This section examines the relationship between Phibro Animal Health Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.64 |
| Latest Market Cap to Assets Ratio | 0.52 |
| Asset Growth Rate (YoY) | 38.6% |
| Total Assets | $1.36 Billion |
| Market Capitalization | $713.39 Million USD |
Valuation Analysis
Below Book Valuation: The market values Phibro Animal Health Corporation's assets below their book value (0.52x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Phibro Animal Health Corporation's assets grew by 38.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Phibro Animal Health Corporation (2000–2025)
The table below shows the annual total assets of Phibro Animal Health Corporation from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $1.36 Billion | +38.56% |
| 2024-06-30 | $982.18 Million | +1.11% |
| 2023-06-30 | $971.40 Million | +4.26% |
| 2022-06-30 | $931.70 Million | +10.74% |
| 2021-06-30 | $841.33 Million | +7.30% |
| 2020-06-30 | $784.10 Million | +7.90% |
| 2019-06-30 | $726.67 Million | +8.19% |
| 2018-06-30 | $671.68 Million | +7.74% |
| 2017-06-30 | $623.40 Million | +2.13% |
| 2016-06-30 | $610.37 Million | +23.73% |
| 2015-06-30 | $493.32 Million | +4.45% |
| 2014-06-30 | $472.32 Million | -0.38% |
| 2013-06-30 | $474.14 Million | +7.54% |
| 2012-06-30 | $440.91 Million | +21.92% |
| 2009-06-30 | $361.63 Million | +11.24% |
| 2008-06-30 | $325.07 Million | +19.56% |
| 2007-06-30 | $271.90 Million | +9.50% |
| 2006-06-30 | $248.30 Million | -1.90% |
| 2005-06-30 | $253.10 Million | +4.85% |
| 2004-06-30 | $241.40 Million | -11.99% |
| 2003-06-30 | $274.30 Million | -7.46% |
| 2002-06-30 | $296.40 Million | -10.18% |
| 2001-06-30 | $330.00 Million | +27.66% |
| 2000-06-30 | $258.50 Million | -- |
About Phibro Animal Health Corporation
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including po… Read more